○Azusa Sano1, Keito Ogawa1, Yuki Shinozaki1, Hiroki Tanimoto1, Takenori Tomohiro1 (1. Fac. Pharm. Sci., Univ. of Toyama)
Session information
Poster Presentation
(A) Pharmaceutical Chemistry
[27P1-pm2] Chemical biology/Drug design/Natural medicines and biological products/Pharmacologically active compounds/Structure-activity relationship/Others
Mon. Mar 27, 2023 3:40 PM - 5:20 PM [Room P1] Gymnasium (1F)
○Nami Ohashi1, Arimi Miura1, Hiroaki Ishida1, Toshimasa Itoh1 (1. Showa Pharm. Univ.)
○Takuto Nagao1, Naoya Shindo1, Akio Ojida1 (1. Grad. Sch. Pharm. Sci., Kyushu Univ.)
○Wakana Yamada1, Shinichi Sato1,2, Minoru Ishikawa1, Shusuke Tomoshige1 (1. Grad. Sch. Life Sci., Tohoku Univ., 2. FRIS., Tohoku Univ.)
○Tetsuya Yano1, Takahiro Yamada1, Hiroaki Ishida1, Nami Ohashi1, Toshimasa Itoh1 (1. Showa Pharm. Univ.)
Withdrawn
Mami Yoshizawa1, Eri Shimizu1, Nami Ohashi1, Hiroaki Ishida1, Takahiro Yamada1, ○Toshimasa Itoh1 (1. Showa Pharm. Univ.)
○Yuna Yamada1, Yuta Fujikawa1, Hijiri Oshio2, Shiiba Isshin2, Yanagi Shigeru2, Hideshi Inoue1 (1. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci., 2. Fac. Sci., Gakushuin Univ.)
○Mieko Tsuji1, Tasuku Hirayama1, Hideko Nagasawa1 (1. Gifu Pharm Univ.)
○Ryo Kawana1, Tasuku Ueno1, Yasuteru Urano1,2 (1. Grad. Sch. Pharm. Sci., Univ. of Tokyo, 2. Grad. Sch. Med., Univ. of Tokyo)
○Masayuki Fujii1, Yojiro Kotake1, Yasuo Shiohama2 (1. Sci Tech., Kindai University, 2. Sch. Med., University of Yamaguchi)
[27P1-pm2-087] Solid-phase synthesis of unnatural polyamines and its effect on DNA thermal stability
○Naoki Umezawa1, Masashi Yamaguchi1, Yosuke Hisamatsu1, Tsunehiko Higuchi1 (1. Grad. Sch. Pharm. Sci., Nagoya City Univ.)
○Kaori Ota1, Makoto Furutachi1 (1. Fukuoka University)
○Koichi Shikama1, Kenta Ogawa1, Jun Takayama1, Meiyan Xuan1, Hirokazu Matsuzaki1, Bo Yuan1, Mari Okazaki1, Takeshi Sakamoto1 (1. Fac. Pharm. Sci., Josai Univ.)
○Kazuma Komai1, Koichi Shikama1, Kenta Ogawa1, Jun Takayama1, Meiyan Xuan1, Hirokazu Matsuzaki1, Bo Yuan1, Mari Okazaki1, Takeshi Sakamoto1 (1. Fac. Pharm. Sci., Josai Univ.)
○Takuma Okusawa1, Koichi Shikama1, Jun Takayama1, Meiyan Xuan1, Hirokazu Matsuzaki1, Bo Yuan1, Mari Okazaki1, Takeshi Sakamoto1 (1. Fac. Pharm. Sci., Josai Univ.)
○Ken-ichi Iwamoto1, Ryodai Enomoto1, Atsukazu Kuwahara2, Yasutada Akiba3, Jonathan D. Kaunitz3, Kei Manabe1 (1. University of Shizuoka, 2. Yamagata University, 3. University of California, Los Angels)
○Takuto Ichikawa1, Kazuya Nakayama1, Yuya Moriguchi1, Risa Togo1, Kentaro Kawai1, Yukiko Karuo1, Atsushi Tarui1, Kazuyuki Sato1, Kazuyuki Kitatani1, Masaaki Omote1 (1. Dep. Pharm. Sci., Setsunan Univ.)
○Kenta Kawamoto1, Hiroki Ueda2, Minoru Suzuki2, Yoshinori Sakurai2, Tomohiro Tanaka3, Shin Aoki1,4 (1. Faculty of Pharmaceutical Sciences, Tokyo University of Science , 2. Institute for Integrated Radiation and Nuclear Science, Kyoto University , 3. Okayama univ., 4. Research Institute for Science and Technology, Tokyo University of Science)
○Hiroaki Ishida1, Honami Ozawa1, Toshimasa Itoh1 (1. Showa Pharm. Univ.)
○Yusuke Iguchi1, Misato Azumaya1, Yuka Kakinami1, Yukiko Yamashita1, Mizuho Une1 (1. Fac. Pharm. Sci., Hiroshima International Univ.)
○Akiho Niitsu1, Ryota Yamamoto1, Yu Sanada2, Tsubasa Watanabe2, Shinichiro Masunaga2,3, Mieko Tsuji1, Tasuku Hirayama1, Hideko Nagasawa1 (1. Gifu Pharm. Univ., 2. KURNS, 3. Hanwa Daini Senboku Hospital)
○Jui-Yi Hsu1, Chia-Ron Yang2, Wei-Jan Huang*3, Kai-Cheng Hsu*4 (1. Ph.D. Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei, Taiwan, 2. School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan, 3. School of Pharmacy, Taipei Medical University, Taipei, Taiwan, 4. Graduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan)
○Yi-Han Chang1, I-Ting Wu2, Chin-Chuan Hung2, Hsin-Yi Hung1 (1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University, Tainan, Taiwan, 2. Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan)
Hiroaki Yabuuchi2, ○Ryuji Kasamatsu1, Kazuhito Hayashi1, Makiko Fujiwara1, Takeshi Ogusu1, Megumi Mori1, Kazuyuki Miyai1 (1. WINTEC, 2. Wakayama Prefectural Higashimuro Promotions Bureau)
○Kensuke Yotsumoto1, Katura Sano1, Ayano Kinjo1, Hiroyuki Fuchino2, Motoko Igarashi2, Atsuyuki Hishida2,3 (1. ALBION CO., LTD., 2. National Institutes of Biomedical Innovation, Health and Nutrition, 3. Tokyo University of Agriculture)
○Hikari Imazu1, Mitsuaki Yamashita1, Youchi Fukuda1, Akira Iida1 (1. Sch. Agri., Kindai Univ.)
○Minami Koya1, Mitsuaki Yamashita1, Iida Akira1 (1. Sch. Agri., Kindai Univ.)
○Arisa Tsukamoto1, Mitsuaki Yamashita1, Akira Iida1 (1. Grad. Sch. Agric., Kindai Univ.)
○Tadahiro Etoh1, Yuki Sato1, Ryoto Meguro1, Fuma Hiki1, Miyu Toda1, Sakurako Tanaka1, Hiromi Torii1, Kurumi Aayabe1, Yong pil Kim1,2 (1. Fac. Pharm., Iryo Sosei Univ., 2. Grad. Sch. Life Sci. Technol., Iryo Sosei Univ.)
○Kenya Okamoto1, Natsumi Tsuchiya1, Azuki Moriyama1, Shuhei Nakao1, Miyuki Mabuchi1, Tadashi Shimizu1 (1. Sch.Pharm.Hyogo Medical Univ.)
○Nagisa Sasaki1, Yukina Shinozaki1, Yosinori Okuno1, Shigeki Isomura1, Miho Sawada2, Yukihiro Itoh2, Takayoshi Suzuki2, Yasuo Sato1 (1. Yokohama University of Pharmacy, 2. ISIR Osaka University)
○Susumu Shinya1, Kentaro Kawai1, Naoki Kobayashi2, Yukiko Karuo1, Atsushi Tarui1, Kazuyuki Sato1, Masato Otsuka1, Masaaki Omote1 (1. Fac. Pharm. Sci., Setsunan Univ., 2. Dep. Agric., Setsunan Univ.)
○Tatsuya Takahashi1, Kaito Ohta1, Yuri Tatsuishi 1, Shota Ando1, Chiami Moyama1, Hiromi Ii 1, Susumu Nakata1, Hiroki Iwaski 1, Masayuki Yamashita1, Hisanori Nambu1, Naoto Kojima1 (1. Kyoto Pharm Univ)
○Takumi Saito1, Sayaka Ohrui1, Minami Takanashi1, Shunsuke Kasuya1, Masanori Tayu1, Yukiko Ishikawa2, Yoko Irukayama2, Masashi Yanagisawa2, Nozomi Saito1 (1. Meiji Pharm. Univ., 2. WPI-IIIS, Univ. Tsukuba)
○Yasunari Otsuka1, Eijiro Umemura1, Yukimi Takamiya1, Teruhisa Ishibashi1, Chigusa Hayashi1, Keiko Yamada2, Masayuki Igarashi1, Masakatsu Shibasaki1, Yoshiaki Takahashi1 (1. IMC, 2. Meiji Seika Pharma)
○Hiroyuki Miyachi1, Kayoko Kanamitsu1, Mayumi Ishii1, Eri Watanabe1, Yukina Sato2, Takayuki Osada2, Yuuki Yamazaki2, Hitoshi Kashiwagi2, Mitsuru Sugawara2, Satoshi Shuto2, Yasuteru Shigeta3, Mizuki Watanabe2, Katsumi Maenaka2 (1. DDI, Grad. Sch. Pharm. Sci., TOKYO university, 2. Grad. Sch. Pharm. Sci., HOKKAIDO university, 3. Cent. comp. Sci., TSUKUBA Univ)
○Rina Tsujioka1, Rikito Suzuki1,2, Daphne R. Mattos3, Kazuya Kobayashi1, Jane E. Ishmael3, Kerry L. McPhail3, Shinya Oishi1,2 (1. Kyoto Pharm. Univ., 2. Grad. Sch. Pharm. Sci., Kyoto Univ., 3. Oregon State Univ.)
○Taguchi Hiroaki1, Ryouta Isshiki1, Arisa Matsuo1, Satoshi Nakagawa1, Emi Hifumi2, Taizou Uda3 (1. Grad. Sch. Pharm. Sci. Suzuka Univ. Med. Sci., 2. Res. Manag., Ohita Univ., 3. Ins. Sys., Inf. Tech. and Nanotech.)
○Takuji Shoda1, Hisayo Aoki1, Yosuke Demizu1, Tomoaki Sakamoto1 (1. Natl. Inst. Health Sci.)